Zhifei Awarded Top 100 Chinese Pharmaceutical Enterprises in 2018 and Other Honors

On June 4, 2019, the Release Conference of the Most Influential Chinese Pharmaceutical Brands 2018 and the 11th China (Jinan) Pharmaceutical Industry Development Summit Forum sponsored by the All-China Federation of Industry and Commerce Medical & Pharmaceutical Industry Chamber were held in Jinan, at which Chongqing Zhifei Biological Products Co., Ltd (“Zhifei”) was granted several honors such as Top 100 Chinese Pharmaceutical Enterprises in 2018 and Top 50 Chinese Growth-orientated Pharmaceutical Enterprises in 2018.

The Most Influential Chinese Pharmaceutical Brands has been released for five consecutive years and is the annual brand pageant of the Chinese pharmaceutical industry. The release conference this year released 12 ranking lists including Top 100 Chinese Pharmaceutical Enterprises in 2018 and Top 50 Chinese Growth-orientated Pharmaceutical Enterprises in 2018, which would be published and widely publicized by the media to get more public attention to the core sectors of China’s pharmaceutical industry and the development trend and to drive the development of the pharmaceutical industry.

As a large listed Chinese pharmaceutical company, Zhifei always follows the principles of “Priority to Social Benefit over Corporate Benefit”. Zhifei attaches importance to research and development, compliance and fine management, devotes itself to R&D and production of high-quality vaccines relying on its own scientific and technological strengths, and provides high-quality and safe vaccines for children and adults. Through unremitting efforts in the past 20 years, Zhifei has been widely recognized by the state, peers and the public. At the release conference of the lists, Zhifei was awarded five honors, including Top 100 Chinese Pharmaceutical Enterprises in 2018, Top 50 Chinese Growth-orientated Pharmaceutical Enterprises in 2018 and Top 100 Chinese Pharmaceutical Distributors in 2018. At the same time, Mr. Jiang Rensheng, chairman and general manager of Zhifei, won the honor of Top 10 New Leaders in Chinese Pharmaceutical Industry in 2018.

These prizes and honors represent the joint efforts and selfless dedication of Zhifei people and demonstrate Zhifei’s commitment and responsibility, and will be taken by Zhifei as a new starting point for another struggling journey of development and a promoter to contribute to the realization of national health strategy.